Author

Z. Pu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1 Microbiology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Organism:mouse· 4 Assay:metagenomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Z. Liu· 3 shared A. Matsui· 2 shared D. G. Duda· 2 shared J. Chen· 2 shared K. Inoue· 2 shared L. Zhu· 2 shared P. Huang· 2 shared Z. Ruan· 2 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Z. Liu

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Rapid intracellular acidification is a novel plant defense response countered by the brown planthopper

Y. Jiang, X.-Y. Zhang, S. Li, Y.-C. Xie, Y. Yang, Z. Pu, L. Zhang, J.-B. Lu, H.-J. Huang, C.-X. Zhang, S. Y. He

The paper identifies NlCA, a salivary carbonic anhydrase from the brown planthopper, as a key factor in modulating rice cell pH to suppress defense responses and facilitate insect survival.

bioRxiv · May 24, 2023Plant Biology

Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy

J. Chen, Z. Amoozgar, X. LIU, S. Aoki, Z. Liu, S. Shin, A. Matsui, Z. Pu, P.-J. Lei, M. Datta, L. Zhu, Z. Ruan, L. Shi, D. Staiculescu, K. Inoue, , D. G. Duda

This paper shows that combining chemotherapy with CTLA-4 blockade reprograms the immune microenvironment of intrahepatic cholangiocarcinoma, enhancing the effectiveness of anti-PD1 therapy.

bioRxiv · Jan 26, 2023Cancer Biology

Integrated transcriptome and lineage analyses reveal novel catecholaminergic cardiomyocytes contributing to the cardiac conduction system in murine heart

T. Sun, A. Grassam-Rowe, Z. Pu, H. Ren, Y. An, X. Guo, W. Hu, Y. Liu, Y. Li, Z. Liu, K. Kou, X. Ou, T. Chen, X. Fan, Y. Liu, , M. Lei

This study identifies a novel catecholaminergic cardiomyocyte population expressing Dbh that contributes to the murine cardiac conduction system through transcriptomic, genetic, and optogenetic analyses.

bioRxiv · Nov 4, 2022 · PreprintCell Biology

Inflammasome targeting with an NLRP3 agonist therapy is feasible but ineffective in murine hepatocellular carcinoma models with liver damage

Z. Pu, Z. Liu, J. Chen, K. Inoue, Z. Ruan, L. Zhu, H. Kikuchi, A. Matsui, P. Huang, D. G. Duda

This study tests an NLRP3 agonist added to PD-1/VEGFR inhibitors in murine HCC models with liver damage, finding it feasible but ineffective in improving tumor outcomes.

bioRxiv · Jun 23, 2022 · PreprintImmunology

Gut microbiome communication with bone marrow regulates susceptibility to amebiasis

S. L. Burgess, J. L. Leslie, M. J. Uddin, N. Oakland, K. Watanabe, C. Gilchrist, G. B. Moreau, M. Saleh, M. Simpson, B. Thompson, D. T. Auble, S. Turner, N. Giallourou, J. Swann, Z. Pu, , W. A. Petri

The paper shows that introducing Clostridium scindens into the gut microbiota epigenetically alters bone marrow and provides protection against Entamoeba histolytica infection.

bioRxiv · Aug 7, 2019Microbiology